chr18-2847891-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032048.3(EMILIN2):āc.217A>Gā(p.Asn73Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032048.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMILIN2 | NM_032048.3 | c.217A>G | p.Asn73Asp | missense_variant | 2/8 | ENST00000254528.4 | NP_114437.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMILIN2 | ENST00000254528.4 | c.217A>G | p.Asn73Asp | missense_variant | 2/8 | 1 | NM_032048.3 | ENSP00000254528 | P1 | |
ENST00000693116.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250302Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135450
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461040Hom.: 0 Cov.: 37 AF XY: 0.00000963 AC XY: 7AN XY: 726828
GnomAD4 genome AF: 0.000118 AC: 18AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.217A>G (p.N73D) alteration is located in exon 2 (coding exon 2) of the EMILIN2 gene. This alteration results from a A to G substitution at nucleotide position 217, causing the asparagine (N) at amino acid position 73 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at